Get started
Author

Alireza Labani‐Motlagh

Observed names: A. Labani-Motlagh, Alireza Labani-Motlagh
Observed institutions: Uppsala University, The University of Texas at Tyler, Science for Life Laboratory, Hackensack Meridian Health, Umeå University, The University of Texas Health Science Center at Tyler
ORCID: 0000-0001-8905-0829
Observed ORCID: 0000-0001-8905-0829
OpenAlex ID: A5083572416
The Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses
2020 · Alireza Labani-Motlagh, Mehrnoush Ashja-Mahdavi, et al. · Frontiers in Immunology · 792
PDF
Differential expression of ligands for NKG2D and DNAM-1 receptors by epithelial ovarian cancer-derived exosomes and its influence on NK cell cytotoxicity
2015 · Alireza Labani-Motlagh, Pernilla Israelsson, et al. · Tumor Biology · 93
Boosting CAR T-cell responses in lymphoma by simultaneous targeting of CD40/4-1BB using oncolytic viral gene therapy
2021 · Jessica Wenthe, Sedigheh Naseri, et al. · Cancer Immunology Immunotherapy · 66
PDF
Bacteriophage therapy for the treatment of Mycobacterium tuberculosis infections in humanized mice
2024 · Fan Yang, Alireza Labani-Motlagh, et al. · Communications Biology · 53
Systemic immunity upon local oncolytic virotherapy armed with immunostimulatory genes may be supported by tumor-derived exosomes
2021 · Alireza Labani-Motlagh, Sedigheh Naseri, et al. · Molecular Therapy — Oncolytics · 53
PDF
Development of a human glioblastoma model using humanized DRAG mice for immunotherapy
2023 · Rashmi Srivastava, Alireza Labani-Motlagh, et al. · Antibody Therapeutics · 22
PDF
The role of NK and NKT cells in the pathogenesis and improvement of multiple sclerosis following disease‐modifying therapies
2022 · Alireza Ahmadi, Zahra Fallah Vastani, et al. · Health Science Reports · 15
PDF
mTORC1 suppression by Trp53 mutation drives resistance to immune checkpoint blockade
2026 · Alireza Labani-Motlagh, Yang Li, et al. · Cell Death and Disease · 2
PDF
Abstract 695: Immunostimulatory gene therapy with an oncolytic virus expressing TMZ-CD40L and 4-1BBL induces oncolysis and show immunomodulatory capacity in soft tissue sarcoma
2023 · Ahmed Calandigary, Alireza Labani-Motlagh, et al. · Cancer Research
Abstract 1689: Exosomes derived from tumor cells treated with immunostimulatory oncolytic virotherapy exert immune activation instead of immunosuppression
2021 · Alireza Labani-Motlagh, Sedigheh Naseri, et al. · Cancer Research
P129 Assessment of cytokine mRNA expression profiles in tumor microenvironment and peripheral blood mononuclear cells of patients with high-grade serous carcinoma of the ovary
2019 · P. Israelsson, A. Labani-Motlagh, et al. · International Journal of Gynecological Cancer
Deregulated expression of lncRNAs in epithelial ovarian cancer tissue can be revealed by probing circulating exosomes : A possible novel approach to cancer diagnosis
2017 · Alireza Labani‐Motlagh
Works count: 12
Citation count: 1,096
H-index: 7
I10-index: 7
Year
Topic
Type